Life Code GmbH

HELLO from Future Labs Live Basel

If you are working on digital labs, R&D data workflows, discovery analytics, translational research, biomarkers, omics, cheminformatics, or AI-ready research infrastructure, I would be very happy to meet you.

helps biopharma R&D teams bring visual clarity into complex biomedical and chemical datasets — integrating public and proprietary data into interactive, traceable workflows. The platform ecosystem includes Ordino, Aevidence and visynKB, with curated access to 80+ biomedical data sources.

Please feel free to reach out here on LinkedIn or come and say hello at the conference when you see me!

I will be at the SWISS BIOTECH DAY 2026 representing Life Code (biopharma forecasting), Psyma+Exevia (biopharma insights) and datavisyn (visual data science enabling biopharma discovery).

Lots to talk about - meet me at the Congress Center in Basel on the 4th and 5th May.

AI Live by our partner firm PSYMA+EXEVIA
Depth and Speed in

https://www.linkedin.com/posts/robert-siegmund_astrazenecas-growth-engine-keeps-firing-activity-7426990526979018754-ZlUh/

AstraZeneca’s Growth Engine Keeps Firing as 2030 Ambitions Take Shape AstraZeneca has reported a solid increase in revenue in 2025, driven by sustained oncology momentum and continued strength… | Robert F. Siegmund, PhD MBA AstraZeneca’s Growth Engine Keeps Firing as 2030 Ambitions Take Shape AstraZeneca has reported a solid increase in revenue in 2025, driven by sustained oncology momentum and continued strength across its core therapy areas. The numbers reinforce a familiar theme: disciplined ex*****on, pipeline de...